Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
Clinical trial NCT04564703 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04564703
- Sponsor
- Stichting European Myeloma Network
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-22
- Primary completion
- 2023-07-27
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.